MET overexpression and amplification define a distinct molecular subgroup for targeted therapies in gastric cancer.
about
MET-targeted therapy for gastric cancer: the importance of a biomarker-based strategy.Combination of histoculture drug response assay and qPCR as an effective method to screen biomarkers for personalized chemotherapy in esophageal cancer.SwissMTB: establishing comprehensive molecular cancer diagnostics in Swiss clinicsMET-overexpressing myxofibrosarcoma frequently exhibit polysomy of chromosome 7 but not MET amplification, especially in high-grade cases: clinical and pathological review of 30 myxofibrosarcoma cases
P2860
MET overexpression and amplification define a distinct molecular subgroup for targeted therapies in gastric cancer.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
MET overexpression and amplifi ...... d therapies in gastric cancer.
@en
type
label
MET overexpression and amplifi ...... d therapies in gastric cancer.
@en
prefLabel
MET overexpression and amplifi ...... d therapies in gastric cancer.
@en
P2093
P2860
P1433
P1476
MET overexpression and amplifi ...... d therapies in gastric cancer.
@en
P2093
Baorui Liu
Cristina Teixido
Wenxian Guan
Xiaoping Qian
P2860
P2888
P304
P356
10.1007/S10120-015-0545-5
P577
2015-09-24T00:00:00Z
P5875
P6179
1027830538